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Abstract
A series of duplication events led to an expansion of clade B Serine Protease Inhibitors (SERPIN), currently displaying a large
repertoire of functions in vertebrates. Accordingly, the recent duplicates SERPINB3 and B4 located in human 18q21.3 SERPIN
cluster control the activity of different cysteine and serine proteases, respectively. Here, we aim to assess SERPINB3 and B4
coevolution with their target proteases in order to understand the evolutionary forces shaping the accelerated divergence
of these duplicates. Phylogenetic analysis of primate sequences placed the duplication event in a Hominoidae ancestor
(,30 Mya) and the emergence of SERPINB3 in Homininae (,9 Mya). We detected evidence of strong positive selection
throughout SERPINB4/B3 primate tree and target proteases, cathepsin L2 (CTSL2) and G (CTSG) and chymase (CMA1).
Specifically, in the Homininae clade a perfect match was observed between the adaptive evolution of SERPINB3 and
cathepsin S (CTSS) and most of sites under positive selection were located at the inhibitor/protease interface. Altogether our
results seem to favour a coevolution hypothesis for SERPINB3, CTSS and CTSL2 and for SERPINB4 and CTSG and CMA1. A
scenario of an accelerated evolution driven by host-pathogen interactions is also possible since SERPINB3/B4 are potent
inhibitors of exogenous proteases, released by infectious agents. Finally, similar patterns of expression and the sharing of
many regulatory motifs suggest neofunctionalization as the best fitted model of the functional divergence of SERPINB3 and
B4 duplicates.
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Introduction
Proteolysis is involved in the regulation of numerous biological
processes being fundamental in every cell and organisms. The
activity of proteases is regulated by a complex network of
inhibitory molecules and different human pathologies such as
arthritis, cancer, neurodegenerative and cardiovascular diseases
can be associated with the deleterious effects of uncontrolled
proteolysis. Thus, the regulation of endogenous proteases is crucial
in the maintenance of organisms’ homeostasis and health status
[1,2].
Serine protease inhibitors (SERPINs) are key elements in the
regulation of proteolytic pathways, controlling the activity of serine
proteases and helping to prevent from the pernicious effect of
excessive proteolysis [1]. Some SERPINs can also inhibit cysteine
proteases, acting as cross-class SERPINs, while others lost their
inhibitory activity and developed other functions as serving as
hormone carriers or chaperones [1,3,4]. SERPIN superfamily
members share a conserved tertiary structure [5] with an exposed
reactive center site loop (RCL), which carries the protease
recognition site and acts as a pseudo-substrate determining
protease specificity [6]. Inhibitory SERPINs regulate protease
activity through a unique suicide mechanism where the RCL
binds to the protease and is then cleaved between P1 and P19
(scissile bond) residues resulting in the formation of a covalent
complex that irreversibly locks both SERPIN and protease [5,7].
Vertebrate SERPINs exhibit distinct exon-intron patterns [8]
and segregate evolutionary into nine clades (A-I) [1]. The clade B
SERPINs differ from other SERPINs by the absence of a signal
peptide and by the occurrence of an additional polypeptide loop
between helices C and D (CD-loop) present in most members [1].
Their localization in the cells is limited to cytoplasm and/or
nuclear compartments where SERPINBs play a cytoprotective
role through the inhibition of proteases involved in cell death [3,4].
However, several SERPINBs (SERPINB2, B3, B5 and B7) [6] can
be released from cells under certain conditions, which in most
cases is thought to result from passive cell loss or lysis [1,4].
Moreover, it has become apparent that these proteins participate
alone or in concert with other molecules in the regulation of
intricate proteolytic cascades implicated in tumor suppression,
apoptosis, inflammation and angiogenesis, among others, through
complex and still-obscure mechanisms [1,9,10].
At the gene level, SERPINBs share a similar structure
comprising seven-eight exons with a translational starting site at
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exon II and the RCL located in the last exon [1]. In humans,
SERPINB genes are organized in tandem at 6p25 (SERPINB1,
B6 and B9) [11,12] and 18q21.3 (SERPINB2, B3, B4, B5, B7,
B8, B10, B11, B12 and B13) chromosomes [13,14]. Comparative
genomics of the human, mouse, chicken and zebrafish sequences
indicates that SERPINB genes undergone an expansion through-
out vertebrate evolution by a series of duplication events [15,16].
In the SERPIN superfamily, events of gene duplication are
likely to underlie the functional diversification of the inhibitory
repertoire of these proteins [16]. Such phenomenon is well
illustrated in vitro by mouse homologues Serpinb3a-d, while
Serpinb3a inhibits both chymotrypsin-like serine proteases and
papain-like cysteine proteases [17], Serpinb3b inhibits both
papain-like cysteine proteases and trypsin-like serine proteases
and no inhibitory activity was detected for Serpinb3c and
Serpinb3d [16]. Likewise, the human homologs SERPINB3 and
B4 (formerly known as squamous cell carcinoma antigen 1
(SCCA1) and 2 (SCCA2) respectively), share a sequence identity of
92% and regulate the activity of distinct proteases and in vitro
experiments demonstrate that SERPINB3 targets cysteine prote-
ases such as the cathepsins L1, L2, K and S (CTSL1, CTSL2,
CTSK and CTSS) [18,19] whereas SERPINB4 is a potent
inhibitor of the serine proteases cathepsin G (CTSG) and mast cell
chymase (CMA1) and a poor inhibitor of CTSS when compared
with SERPINB3 (50 times less efficient) [20].
In a healthy state SERPINB3 and B4 play a major role in cell
protection against cytotoxic molecules mainly through the
inhibition of CTSS that may leak into the cytoplasm as a result
of lysosome failure [4,21,22]. Conversely, in cancer disease
SERPINB3 was found to inhibit apoptosis, circumventing the
mechanism of cell death and favouring tumour growth and
metastization [23–25]. Indeed, the overexpression of SERPINB3
in some types of squamous cell carcinomas, namely uterine cervix
carcinoma, esophagus carcinoma, head and neck carcinomas,
breast carcinoma and hepatocellular carcinoma is correlated with
a poor prognosis [9]. For this reason, SERPINB3 and B4 have
been regarded as important serum biomarkers used for the
diagnostic and prognostic of squamous cell carcinomas [26].
Moreover, SERPINB3 is also up-regulated in patients suffering
from systemic sclerosis, psoriasis, bronchitis and pneumonia [4,27]
and reduced in patients with hepatitis C infection and untraceable
in patients with systemic lupus erythematosus [28].
Besides the role in cancer and autoimmunity, SERPINB3 and
B4 have a dual role in the immune response to pathogens. Recent
studies have shown that SERPINB3 may act as a surface receptor
for the binding of hepatitis B virus to hepatocytes and to peripheral
blood mononuclear cells [29–31]. In contrast, SERPINB3 and B4
can also target extrinsic proteases derived from several pathogens
suggesting a protective role against the deleterious effects of several
pathogenic organisms [32,33].
Interestingly, SERPINB3 and B4 were previously identified as
an example of young gene duplicates under positive selection in
the hominid lineage [34]. Duplication events are regarded as an
important source of innovation underlying the onset of gene
families from a single ancestral gene and contributing to the
increase of complexity in the eukaryotic genomes [35]. Two
alternative models are frequently used to explain the evolution and
retention of duplicate genes in the genomes. The neofunctiona-
lization model [36] that claims the gain of a novel function by a
gene copy as the main reason for the retention of duplicates in the
genome [37]. The subfunctionalization model [38] on the other
hand, predicts lower selective constraints affecting equally both
duplicates in a way that neither copy is sufficient to perform the
original function, and both copies are maintained in the genomes
[37].
Here, we combine phylogenetic based tests and protein
structural analysis to assess the evolution of SERPINB3 and B4
and their target proteases in the view of understanding the
selective forces shaping the divergence of SERPINB3 and B4
duplicates and its potential implications for human health and
disease. Results suggest that SERPINB3 duplicate is evolving
under positive selection supporting the functional divergence
observed in several experimental studies.
Materials and Methods
Sequence data
Genomic DNA sequences for SERPINB3, SERPINB4, CTSS
(Cathepsin S), CTSL1 (Cathepsin L1), CTSL2 (Cathepsin L2),
CTSK (Cathepsin K), CTSG (Cathepsin G) and CMA1 (Chymase)
were retrieved from the National Center for Biotechnology
Information database (NCBI) (http://www.ncbi.nlm.nih.gov) and
University of California Santa Cruz (USCS) Genomic Bioinfor-
matics database (http://genome.ucsc.edu/) for the following
primate species: human (Homo sapiens), common chimpanzee
(Pan troglodytes), gorilla (Gorilla gorilla), Sumatran orangutan
(Pongo abelli), northern white-cheeked gibbon (Nomascus leuco-
genys), rhesus macaque (Macaca mulatta), olive baboon (Papio
anubis), marmoset (Callithrix jacchus) and squirrel monkey
(Saimiri boliviensis) (see Table S1). In the case of G. gorilla, to
fill the large sequence gaps affecting SERPINB4 and CTSS
coding region, we amplified, by polymerase chain reaction (PCR),
and sequenced a G. gorilla sample (EB(JC) from the primate DNA
panel of the European Collection of Cell Cultures (ECACC). We
used MultiPipMaker [39] to build multiple sequence alignments
and the human SERPINB3, SERPINB4, CTSS, CTSK, CTSL1,
CTSL2, CTSG and CMA1 sequences were used to annotate for
gene content in the collected sequences of other primate species.
RepeatMasker (http://www.repeatmasker.org/) was used to de-
tect repetitive sequences. Sequence editing and exon assembly
were performed using Bioedit (7.0.9.1) [40].
Phylogenetic analysis and selection tests
We used CLUSTALW [41] implemented in the MEGA5 [42]
software to align the cDNA sequences of SERPINB3, SER-
PINB4, CTSS, CTSL1, CTSL2, CTSK, CTSG and CMA1.
Phylogenetic trees were then constructed using neighbour-joining
method with 10000 bootstraps implemented in MEGA5.
The nonsynonymous/synonymous substitution rate ratio (dN/
dS =v) was estimated using the maximum likelihood (ML)
framework implemented in the program CODEML of Phyloge-
netic Analysis by Maximum Likelihood (PAML) software [43]. We
used v values to investigate the selective pressures that have
shaped the evolution of SERPINB3 and B4 duplicates and their
known targets CTSS, CTSL1, CTSL2, CTSK, CTSG and CMA1.
We used three likelihood ratio test (LTR) approaches to detect
genes under positive selection: first the branch model evaluates the
strength of natural selection in one or more phylogenetic clades
and compares a single v value obtained for all lineages (M0) with a
model assuming different v values for each lineage (free-ratio);
second, the site models, which allows the v values to vary among
sites of the protein and compares the neutrality models M1a and
M7 against the positive selection models M2a and M8, respec-
tively; third, the branch-site model was used to identify codons
under positive selection within a phylogenetic clade that compares
the null model, with a fixed v= 1 for all the sites in the
background, with the alternative model, assuming a v.1 for all
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the sites in the foreground [44]. In all cases, the significance of the
models was carried out using the likelihood ratio test -2Dl with a x2
distribution [43,44]. The Bayes Empirical Bayes (BEB) approach is
implemented to identify amino acids under positive selection [45].
For v calculation, sequences associated with species-specific stop
codons were removed.
Protein modelling and docking
The three-dimensional (3D) structures of SERPINB3 (2ZV6),
CTSS (2FQ9), CTSL1 (2XU3), CTSL2 (1FH0), CTSLK (3KWZ),
CTSG (1CGH) and CMA1 (4AG1) proteins were obtained from
Protein Data Base (PDB) (http://www.rcsb.org). In the case of
SERPINB4, the 3D structure was predicted by homology
modeling in MODELLER 9.10 software using SERPINB3 as
template [46]. Structure validation was performed with PRO-
CHECK [47] available in SWISS-MODEL web server [48].
After, to assess the possible functional significance of specific
amino acids replacements between SERPINB3 and B4 in the
target protease affinity, the obtained 3D structures were used to
generate 3D structural models of inhibitor-protease complexes
using the HADDOCK docking web server [49] (http://haddock.
science.uu.nl). The published binding residue pairs, namely the P1
and P19 residues, from SERPINB3 and B4, and the amino acids
that form the catalytic triad of target proteases, at the interface
region of the inhibitor-protease complex, were used to drive the
docking process. Visualization of the 3D structures was performed
in PyMol 0.99rc6 [50]. The models were evaluated according to
the HADDOCK score [51], interface root mean square deviation
(iRMSD) and ligand root mean square deviation (lRMSD) [52].
Tissue expression screening of SERPINB3 and SERPINB4
A set of 21 human cDNA samples from different healthy organs
was used to study the tissue pattern of SERPINB3 and B4
expression. Except for the first-strand cDNA from leukocytes
(Clontech), the RNA from the First Choice Human Total RNA
Survey Panel (Ambion) was used as a template to generate cDNA
by RT- PCR using a Superscript III system (Life Technologies).
PCR amplification was performed using the primers 59 –
TGTAGGACTCCAGATAGCAC – 39 and 59- TGTAG-
GACTTTAGATACTGA – 39, designed to be unique to the
target SERPINB3 and B4 cDNA, respectively, and primer 59 -
TGGAAATACCATACAAAGGCA – 39. GAPDH was employed
as control using primers 59 - TCAAGGCTGAGAACGGGAAG -
39 and 59 - AGAGGGGGCAGAGATGATGA - 39 for amplifi-
cation (see Fig. S1).
Results
Reconstructing the origin of SERPINB3 and SERPINB4
duplicates
The chromosomal regions of SERPINB3 and B4 from H.
sapiens, P. troglodytes, G. gorilla, P. abelli, N. leucogenys, M.
mulatta, P. anubis, C. jacchus and S. boliviensis were downloaded
from the USCS and NCBI databases or obtained by direct
Figure 1. Origin of SERPINB3 and SERPINB4 duplicates. A) The organization of SERPINB3 and SERPINB4 loci in human and eight non-human
primates. Relative position to telomere (Tel) and centromere (Cen) is shown. Solid boxes represent functional genes; open boxes represent
pseudogenes. B) Phylogenetic tree of SERPINB3 and SERPINB4 genes with the bootstrap percentages shown at interior nodes and the alignment of
RCL regions (P17-P49). The canonical scissile bond is marked by an arrow and a standard P1 and P19 nomenclature is used to number amino acid
positions N- and C-terminal outward from the scissile bond. AncB3/B4: ancestral SERPINB3/B4 gene.
doi:10.1371/journal.pone.0104935.g001
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sequencing. The SERPINB3 and B4 sequences were retrieved
from the human reference sequence of the chromosome 18
(assembly GRCh37,) in a large genomic segment delimited by
SERPINB7 and SERPINB12 (chr18: c61429197-61222431) and
aligned with the homologous sequences from non-human primates
(see Table S1). Overall, sequence alignments revealed a conserved
pattern of seven coding exons in primates for SERPINB3 and B4
(Fig. S2). However in M. mulatta, P. anubis, C. jacchus and S.
boliviensis one of the duplicates was absent (Fig. 1A). In addition,
the analysis of the predicted cDNA and protein sequences revealed
that P. abelli and N. leucogenys telomeric duplicates have a
premature stop codon in positions 60 and 19, respectively, causing
any resulting protein to be abnormally shortened and suggesting
that these duplicates are in fact pseudogenes.
The phylogenetic tree constructed using functional SERPINB3
and B4 sequences, places the duplication event before the
divergence of H. sapiens, P. troglodytes and G. gorilla (Fig. 1B).
However, the finding of non-functional gene copies in P. abelli
and N. leucogenys species suggests that a duplication event
occurred in a common ancestor of Hominoidae (great apes), after
the separation from the Old World monkeys 29.6 million years
(MY) ago. Interestingly, the protein alignments obtained for the
RCL region in the different primate species suggest the existence
of an ancestral SERPINB3/B4 (AncB3/4) with two possible
scissile bond (P1-P19) compositions either TS or LS (Fig. 1B). The
presence of a SS scissile bond, suggests that the telomeric gene,
named SERPINB3 in humans, arose recently in evolution (about
9 MY ago in Hominidae) as the result of duplication and
functional divergence. Noteworthy, SERPINB3 accumulated
several other differences in the RCL region which are likely to
have contributed to a shift in its protease affinity.
Adaptive evolution of SERPINB3
We performed a maximum likelihood (ML) analysis, using
codeml package in PAML software, to test whether the functional
divergence of SERPINB3 is a result of positive selection [43,44].
Initially, we estimated the v ratio for the entire phylogeny (M0
model) and the independent v ratio for each branch to assess and
characterize the selective pressures acting on SERPINB3/B4
evolution. Overall, the M0 model shows a low value of v for the
entire phylogeny (v<0.67) suggesting a conserved evolution
(v,1). Also, the comparison of M0 versus the free-ratio
(22DlnL = 16.18, p.0.05) suggest that the different lineages
experienced similar evolutionary rates. However, this result is not
unexpected, since averaging across all sites is not a powerful test of
adaptive evolution. Hence, we used likelihood ratio tests to
compare nested models with and without positive selection to look
for evidence of site-specific positive selection in SERPINB3/B4
phylogeny. The comparisons of M1a (nearly neutral) versus M2a
(positive selection) and M7 (beta) versus M8 (beta and v.1) show
significant (p,0.001) evidence of positive selection for SERPINB3
and B4 genes (Table 1). For M2a and M8 models, the BEB
analysis identified the same 17 sites under adaptive evolution (v.
1) with high posterior probability (p.90%) (Table 1).
To test if this signal of positive selection could be connected with
the appearance of SERPINB3 we used the branch-site model test.
This test allows the v ratio to vary among sites in the protein and
across branches in the tree to detect if positive selection was
affecting sites along specific lineages. In the SERPINB3/B4 tree
the likelihood ratio tests, based on the branch-site models, were
significant (p,0.01) only for the foreground branch 1 (Fig. S3),
which includes the lineages from H. sapiens, P. troglodytes and G.
gorilla for the SERPINB3 duplicate (Table 2). Although most
sites are under constrained evolution, the residues 327G, 351G
and 352F were identified by the BEB analysis as being under
positive selection (p.80%) in the SERPINB3 clade (foreground
branch 1).
Finally, to evaluate the structural basis of the positive selection
signatures detected by the ML analyses, we compared SERPINB3
and B4 3D structures. However, since the SERPINB4 3D
structure was not available in the surveyed databases, we used
MODELLER software to calculate a homology model of
SERPINB4 using the crystal structure coordinates of SERPINB3
as template (Fig. 2). Structural superimposition of the modelled
SERPINB4 structure with the SERPINB3 template showed a very
low root mean square deviation (RMSD) of 0.22 A˚, which reveals
a quite similar protein backbone.
From the 17 sites under positive selection identified by the site-
model analysis, seven correspond to differences in the RCL from
SERPINB3 and B4 mainly V351G, V352F, E353G, L354S,
S356P, P357T and C364H (Fig. 2). As mentioned above, the RCL
is a crucial region for the interaction with the target proteases
being responsible for the functional SERPIN specificity, in which
these 7 residues are likely to have a significant effect. Also, residue
C279R is located at b-sheet C, in the gate domain (Fig. 2), a
important region for the full insertion of RCL after protease
cleavage [53]. Thus, amino acid alterations in this region could
affect the RCL insertion and the SERPIN inhibitory mechanism.
Finally, from the remaining eight sites under positive selection, six
residues cluster together at the distal end of RCL (Fig. 2). Once
inserted inside the molecule the RCL presses the target protease
against the bottom of the SERPIN resulting in the distortion of the
protease active site, greatly reducing the enzyme catalytic activity
[5]. Consequently, amino acids positioned at the distal end of the
RCL are in close proximity to the inhibited protease and
substitutions in these sites are probably implicated in the stability
of the inhibitor-protease complex.
Furthermore, branch-site model analysis identified the amino
acid K327G and the RCL V351G and V352F residues as being
under positive selection in SERPINB3 duplicate for H. sapiens,
P. troglodytes and G. gorilla lineage. In the case of SERPINB3,
amino acids 351G and 352F are located in the RCL, very close to
Table 1. Maximum likelihood estimates of positive selection for SERPINB3/B4 phylogeny.
Phylogeny N M1avs. M2a M7vs. M8 Proportion of sites v.1 Positively selected sites a
SERPINB3/B4 9 88.97** 89.35** v= 7.12, p = 0.01 17Q, 24E, 163I, 166G, 167N, 171N, 279R, 321R, 324V, 351G, 352F,
353G, 354S, 356P, 357T, 358S, 364H
Likelihood ratio tests (22Dl) comparing a null and positive selection models (M1a vs M2a, M7 vs M8); N, number of primate species with sequences in alignment;
p: proportion of sites under positive selection in M8 model; v: estimate the dN/dS of the sites under selection in M8 model; a Amino acid sites found to be under
positive selection with posterior probabilities greater than 90% (blank), 95% (underlined) or 99% (bold) in the BEB analysis. The reference sequence is human SERPINB3.
** Significance with p,0.001.
doi:10.1371/journal.pone.0104935.t001
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the 354S/355S scissile bond, and may have a relevant functional
role in the specificity of SERPINB3 towards cysteine target
proteases and in its functional divergence from SERPINB4.
Amino acid 327G is located in the highly conserved b-sheet A in
the shutter domain (Fig. 2) that has a key role in SERPIN suicide
mechanism. Once cleaved by a protease the exposed RCL
undergoes drastic conformational alterations ending inside of the
SERPIN, inserted into the b-sheet A region. As a result, many of
the RCL become buried with a major impact in the rate of RCL
insertion [5]. Since the RCL of SERPINB3 and B4 differ in their
amino acid compositions, the substitution of a polar residue, lysine
(SERPINB4) by a stereochemically different glycine (SERPINB3)
could be of crucial importance for an efficient insertion of
SERPINB3 RCL.
Target protease evolution
Furthermore, maximum likelihood approaches were used to
address the evolutionary signatures of SERPINB3 and B4 target
proteases and to check for similar evolutionary paths that could
point to a possible coevolution process between inhibitor and
target proteases mainly CTSS, CTSL1, CTSL2, CTSK, CTSG
and CMA1. As for SERPINB3/B4 phylogeny, the one ratio (M0)
model tests reveal a v,1 suggesting an overall conserved
evolution for the CTSS, CTSL1, CTSL2, CTSK and CMA1
phylogenies. However, CTSG shows higher v ratios (v<0.98),
which suggests a relaxation in the selective constrains. Also, the
comparison of M0 versus the free-ratio model indicates that the
different lineages experienced similar evolutionary rates, except for
CTSS gene (Table 3) in which selective pressures may differ across
CTSS tree branches. We then proceeded to more powerful and
Table 2. Likelihood ratio test for branch-site model for SERPINB3/B4 phylogeny.
Phylogeny Parameter estimates Foreground vs. Background 22Dl Positively selected sites
SERPINB3/B4 Foreground 1 p0 = 0.612, p1 = 0.376, p2a = 0.008, p2b = 0.005, v0 = 0.018, v1 = 1.000, v2 = 19.207 6.10** 327G, 351G, 352F
SERPINB3/B4 Foreground 2 p0 = 0.630, p1 = 0.369, p2a = 0.000, p2b = 0.000, v0 = 0.023, v1 = 1.000, v2 = 1.000 0 NA
22DL, likelihood ratio test to detect positive selection with 1 degree of freedom; Foreground 1: H. Sapiens B3, P. Troglodytes B3 and G. Gorilla B3 lineages; Foreground 2:
H. Sapiens B4, P. Troglodytes B4 and G. Gorilla B4 lineages. Amino acid sites found to be under positive selection with posterior probabilities greater than 80% (blank) are
displayed; NA, not applicable because the neutral model fits better than positive selection.
** Significance with p,0.01.
doi:10.1371/journal.pone.0104935.t002
Figure 2. X-ray structure of SERPINB3 and predicted structure of SERPINB4. The A b-sheet (shutter) is in orange, B b-sheet (breach) is in red
and C b-sheet (gate) is in blue. Helices are shown in green. RCL: reactive center loop. Sites under positive selection are in black.
doi:10.1371/journal.pone.0104935.g002
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robust approaches to test for evidence of site-specific positive
selection across the entire phylogeny or within a specific
phylogenetic clade for CTSS, CTSL1, CTSL2, CTSK, CTSG
and CMA1. The comparisons of M1a (nearly neutral) versus M2a
(positive selection) and M7 (beta) versus M8 (beta and v.1) show
that CTSL2, CTSG and CMA1 genes are under positive selection
(Table 3) and several codons were identified as subject to positive
selection. Interestingly, in a previous work both CTSG and CMA1
were shown to be under positive selection in mammalians, possibly
as a result of a trade-off between increased response to pathogens
and decreased risk of autoimmunity by apoptosis related genes
[54]. Furthermore, branch-site models were used to detect if
positive selection was affecting sites along specific clades in CTSS,
CTSL1, CTSL2, CTSK, CTSG and CMA1 phylogeny and
establish whether selective pressures varied in a similar way as
for SERPINB3/B4 gene tree suggesting inhibitor/target coevo-
lution. Interestingly, we found evidence of positive selection (p,
0.05) for CTSS gene (Table 4), when comparing the foreground
H. sapiens, P. troglodytes and G. gorilla clade with the background
phylogeny (Fig. S4) and we detected residue 255R as being under
positive selection (p.90%). Therefore, positive selection might be
acting in SERPINB3 duplicate and CTSS for H. sapiens, P.
troglodytes and G. gorilla lineage which can point to a possible
coevolution between inhibitor and target protease. No statistical
significance was obtained for the H. sapiens, P. troglodytes and G.
gorilla clade (foreground) in the remaining branch-site tests
(CTSL1, CTSL2, CTSK, CTSG and CMA1).
Finally, to evaluate the functional impact of the sites identified
as being under positive selection in SERPINB3/B4 and target
proteases, we built 3D structures of human SERPINB3- and B4-
target complexes. The HADDOCK outcomes for the best models
(Table 5) are consistent with the known inhibitory activity for
SERPINB3 and B4 published in previous studies [18,19]. Except
for SERPINB4/CTSS complex, HADDOCK generated good
predictions with i-RMSD#2 A˚ and l-RMSD#5 A˚ [52]. Interest-
ingly, the bad quality prediction for SERPINB4/CTSS complex
(i-RMSD$4 A˚ and l-RMSD$10 A˚) is consistent with previous in
vitro results that show the low inhibitory activity of SERPINB4
towards CTSS, 50 times less than SERPINB3 [20].
Figure 3 shows the 3D structures of SERPINB3/CTSS and
SERPINB4/CTSG complexes as representatives of inhibitor-
proteases complexes. The seven RCL residues identified by the
site-model tests as under positive selection for SERPINB3/B4
phylogeny (Table 1) (V351G, V352F, E353G, L354S, S356P,
P357T and C364H), are in the inhibitor/protease interface, in
close proximity to the activity site of the target protease (Fig. 3).
Overall, the RCL plays a critical role in the inhibitory activity of
SERPINs and some studies highlight this notion by showing that
the target specificities of SERPINB3 and B4 could be reversed
solely by swapping their RCL [18]. Moreover, as experimentally
reported, single amino acid substitutions in the RCL region were
unable to convert SERPINB4 in a more efficient cysteine protease
inhibitor. In the particular case of CTSS inhibition, different
combinations of mutations at SERPINB4 positions P2, P29, P39
and P109 led to an increase in CTSS inhibition accounting for
80% of the difference in SERPINB3 and B4 activity [55].
Interestingly, the P2, P29, P39 and P109 positions correspond to the
residues E353G, S356P, P357T and C364H, respectively, which
were found to be under strong positive selection in the present
study. Furthermore, the residue V352F, in position P3, is a key
residue for specificity and binding of papain-like cysteine proteases
and in the case of CTSS the preferred P3 residues are bulky
hydrophobic, as phenylalanine residue in SERPINB3 [18]. In
addition, P1 position (L354S) was found to be under positive
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selection and several mutagenesis studies show that the P1 residue
is usually the most important for SERPIN protease specificity [5].
The 3D structures of SERPINB3/CTSS (Fig. 3), SERPINB4/
CMA1 and SERPINB4/CTSG (Fig. 3) reveal that several residues
under positive selection (Table 3 and Table 4) are located in the
loops surrounding the enzyme catalytic pocket, which have been
shown to be involved in substrate specificity and in enzyme
activation [54]. Also, the location of these residues in loops near to
the enzyme catalytic pocket may suggest a possible role in the 3D
conformation assumed by this region. Moreover, X-ray analysis of
the SERPIN-protease inhibition complexes reveals that the
distortion of protease activity is due to the compression of the
loops surrounding the protease active site against the basis of the
SERPIN. Hence, an amino acid substitution in the protease loops
neighbouring the active site could have physical implications in the
inhibition mechanism [5] and contribute for the functional
divergence of SERPINB3 and B4.
Tissue expression pattern of SERPINB3 and SERPINB4
A panel of 21 tissues was used to determine the expression
pattern of SERPINB3 and B4. As shown in figure 4, SERPINB3
and B4 transcripts were found in uterus, esophagus, lung, prostate,
testis and trachea tissues, whereas in bladder and thymus only the
expression of SERPINB3 was detected (Fig. 4). These expression
patterns are consistent with the ones obtained by Cataltepe and
colleagues, who have shown that SERPINB3 and B4 are
frequently co-expressed in several adult human tissues at both
mRNA and the protein levels [27]. In addition, these findings fit
the expectations of two recent duplicates being more likely to share
cis-regulatory motifs and to display stronger co-expression patterns
than two randomly selected genes [56]. The ENCODE annotation
of transcript factors by CHIP-seq for SERPINB3 and B4
available in UCSC database (http://genome.ucsc.edu/) confirms
that these duplicates still share several regulatory motifs, including
STAT3, CEBPB, FOS and JUN (Fig. S5), which are associated to
immunity and apoptosis pathways. Furthermore, upstream of
SERPINB3 there is an active regulatory region, identified by an
H3K27Ac histone mark, and multiple transcripts factors which
possibly affect both duplicates (Fig. S5). Therefore, the similar
expression pattern of SERPINB3 and B4 is best explained by the
low divergence in the cis-regulatory motifs contrasting with
functional specialization into cysteine and serine inhibitors,
respectively.
Finally the expression sequence tag (EST) profile of CTSS,
CTSL1, CTSL2, CTSK, CTSG and CMA1 target proteases was
assessed revealing an overlap with SERPINB3 and B4 expression
pattern in several tissues (Fig. S6).
Discussion
In the present work, we evaluate the evolutionary forces forging
the recent duplicates SERPINB3 and B4 and address their
functional impact in protein structure, inhibitor-protease interac-
tion and gene expression regulation. Phylogenetic analysis reveals
that a duplication event, at approximately 29.6 MY ago, gave rise
to SERPINB3 and B4 paralogs, stably retained in H. sapiens, P.
troglodytes and G. gorilla genomes, but not in P. abelli and N.
leucogenys species, which carry a pseudogene and an ancestral
Table 4. Likelihood ratio test for branch-site model for target proteases using H. sapiens, P. troglodytes and G. gorilla lineage as
foreground.
Gene Parameter estimates Foreground vs. Background -2DlnL Positively selected sites
CTSS p0 = 0.802, p1 = 0.188, p2a = 0.008, p2b = 0.002, v0 = 0.001, v1 = 1.000, v2 = 48.657 5.38* 255R
CTSL1 p0 = 0.678, p1 = 0.321, p2a = 0.000, p2b = 0.000, v0 = 0.051, v1 = 1.000, v2 = 1.000 0 NA
CTSL2 p0 = 0.679, p1 = 0.320, p2a = 0.000, p2b = 0.000, v0 = 0.000, v1 = 1.000, v2 = 1.000 0 NA
CTSK p0 = 0.549, p1 = 0.066, p2a = 0.343, p2b = 0.041, v0 = 0.000, v1 = 1.000, v2 = 1.000 0 NA
CTSG p0 = 0.421, p1 = 0.540, p2a = 0.017, p2b = 0.021, v0 = 0.000, v1 = 1.000, v2 = 7.081 0.98 NA
CMA1 p0 = 0.331, p1 = 0.200, p2a = 0.292, p2b = 0.177, v0 = 0.000, v1 = 1.000, v2 = 2.196 0.17 NA
22DL, likelihood ratio test to detect positive selection; Foreground: H. sapiens, P. troglodytes and G. gorilla lineage. *Significance with p,0.05; Positively selected sites,
amino acid sites found to be under positive selection with a posterior probabilities greater 90%; NA, not applicable because the neutral model fits better than positive
selection.
doi:10.1371/journal.pone.0104935.t004
Table 5. Inhibitor protein complexes tested by docking analysis.
Model HADDOCK score i-RMSD l-RMSD
SERPINB3/CTSK 288.3+/22.3 0.58+/20.39 1.30+/20.87
SERPINB3/CTSL1 262.0+/215.7 1.04+/20.91 3.09+/23.18
SERPINB3/CTSL2 275.0+/24.2 0.38+/20.25 0.778+/20.59
SERPINB3/CTSS 296.1+/24.4 0.43+/20.30 1.06+/20.73
SERPINB4/CTSS 274.1+/27.0 16.23+/20.35 35.47+/21.05
SERPINB4/CMA1 285.8+/27.5 0.52+/20.36 1.48+/21.07
SERPINB4/CTSG 274.5+/25.6 0.47+/20.32 1.02+/20.75
i-RMSD: interfacial root mean square deviation; l-RMSD: ligand root mean square deviation; HADDOCK score is weighted sum of van der Waals, electrostatic, desolvation
and restrained violation energies together with buried surface area.
doi:10.1371/journal.pone.0104935.t005
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gene (AncB3/B4) instead. In the SERPINB3/B4 phylogeny,
evolutionary tests disclosed a clear signature of positive selection in
the substitution rates across the nine primate species studied, H.
sapiens, P. troglodytes, G. gorilla, P. abelli, N. leucogenys, M.
mulatta, P. anubis, C. jacchus and S. boliviensis. Also, the branch-
site test shows that in the H. sapiens, P. troglodytes and G. gorilla
clade, the SERPINB3 copy is evolving under positive selection
supporting the functional divergence observed in several experi-
mental studies.
In this context we can consider two scenarios, either the
duplication led to the acquisition of a complete new function by
one of the duplicates or a subdivision of the ancestral function
occurred to accommodate an improved inhibitory activity. Under
a subfunctionalization hypothesis, after the duplication event both
copies would maintain the original function and several degener-
Figure 3. The best docking for SERPINB3 (green)/CTSS (blue) and SERPINB4 (green)/CTSG (blue) complex models generated using
HADDOCK software. Amino acids under positive selection at the SERPIN/protease interface are in black. Amino acids at the inhibitor scissile bond
and forming the proteases catalytic triad are depicted in red. Arrows point the location of b-sheet A (SA), b-sheet B (SB) and b-sheet C (SC). Binding
regions are enlarged for a more detailed view (left panel).
doi:10.1371/journal.pone.0104935.g003
Figure 4. Expression patterns of SERPINB3 and SERPINB4 in human tissues. GAPDH amplification was used as a control. NC: negative
control.
doi:10.1371/journal.pone.0104935.g004
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ative mutations would be tolerated by SERPINB3 and SER-
PINB4, due to a relaxation of selective constrains. However, this
model fails to explain the different hits of positive selection
detected for the entire SERPINB3/B4 phylogeny and for the
SERPINB3 clade alone. Likewise, the subfunctionalization theory
predicts an expression diversification where duplicates sharing the
same function become specialized in different tissues or develop-
mental stages [38], which is not the case of SERPINB3 and B4.
Instead, the neofunctionalization model seems to fit better the
evolutionary history of SERPINB3 and B4 duplicates. According
to this model a copy is kept under purifying selection and retains
the original function while the other is targeted by positive
selection and experiences the accumulation of several amino acid
substitutions ultimately leading to a novel function.
Several studies have demonstrated that positive selection
frequently occurs in concert with duplication events in genes
involved in brain function and cell growth [57,58], reproduction
[59], endurance running [60] and in xenobiotic recognition of
macromolecules [61]. In addition, several gene families implicated
in the immune system were proposed as targets of positive
selection [62,63]. There, gene duplications are considered a
important mechanism in the enlargement of host defence
repertoire, which is crucial for a rapid response to changing
environments and to a increased burden of pathogens [64]. For
instance, the tripartite motif (TRIM) protein family, a group of
innate antiviral effectors, experienced several episodes of strong
positive selection showing high levels of sequence divergence
between paralogs and a wide range of antiviral activities possibly
resulting from different attempts to counteract fast evolving viruses
[65].
Similarly, evidence for positive selection was detected in several
members of the SERPIN superfamily. SERPINB11, a highly
conserved gene in primates, was lost and resurrected in humans
where the accumulation of several mutations contributed to the
appearance of a modified non-inhibitory SERPIN, probably
linked to an adaptive response against the emergence of infectious
diseases in recent human evolution [66]. Also, in SERPINA2, a
90 MY old duplicate of alpha1-antitrypsin (SERPINA1), several
sites seem to be under positive selection in primates, contributing
to the emergence of a new advantageous function, possible as a
chymotrypsin-like inhibitor [67]. Conversely, a large deletion in
SERPINA2 was proposed to be selective advantageous in Africans
through a potential role in fertility or in host–pathogen interac-
tions (Seixas, et al 2007).
Such recent studies are in agreement with earlier assumptions
based mostly in human and rodent sequences that established a
link between RCL hypervariability, SERPIN superfamily func-
tional diversity and positive selection acting after gene duplication
[68–70]. Furthermore, Hill and Hastie postulate that these
adaptive changes were fixated because SERPINs were challenged
by exogenous proteases brought in by infectious agents, which
may indicate an ongoing host-pathogen coevolution [69].
Likewise, we propose that the SERPINB3/B4 selective
signatures are the result of a coevolution process involving either
endogenous or exogenous target proteases. Indeed, the structural
and docking analyses are in line with previous biochemical studies
[19,55], showing that many of the putatively selected sites fall in
regions important for the inhibitor function promoting functional
divergence between SERPINB3 and B4. Also, the ability of
SERPINB4 to inhibit CTSS, as well as other papain-like cysteine
proteases, at a rate 50-fold slower than that of SERPINB3 [55]
may suggest that the functional divergence of these two inhibitors
is still ongoing. Finally, the scenario of functional divergence is
strengthened by the consistence of selective signatures of
SERPINB4 targets, CMA1 and CTSG in the primates (our
study) and mammalian phylogenies [54,71]. Since CMA1 and
CTSG are powerful proteases involved in programmed cell death
(apoptosis) and in the immune response, an evolution of these
molecules driving by host-defence is also likely. Hence, selective
hallmarks observed throughout SERPINB3/B4 phylogeny can
result from an adaptive response to CMA1 and CTSG evolution.
The overlap of CTSS and SERPINB3 selective signatures in
the H. sapiens, P. troglodytes and G. gorilla clade points as well for
a possible coevolution of these molecules. Interestingly, both
CTSS and SERPINB3 are found in endosome/lysosome struc-
tures in macrophage [72] and B cells [28] where CTSS is thought
to be engaged in antigen presentation through the degradation of a
major histocompatibility complex class II chain [73].
Aside from a role in innate immunity through the regulation of
endogenous proteases, SERPINB3 may also be enrolled in the
host-pathogen response by the inhibition of cysteine proteases
released in the infectious processes by Staphylococcus aureus
(staphopains) [33], Leishmania Mexicana (CPB2.8), Trypanosoma
cruzi (cruzain), T. brusei rhodesience (rhodesain) and Fasciola
hepatica (cathepsin L2) [32]. Worth to note, SERPINB3 is
expressed in squamous epithelium of mucous membranes, skin
and the respiratory system, where it may act as a primary host-
defence mechanism by preventing pathogens to cross and disrupt
epithelial barriers. Moreover, the regulation of SERPINB3
expression by the transcription factors STAT3, CEBPB and
FOS/JUN AP-1 complex, which are involved in the development
and modulation of the immune system, regulation of cell
proliferation and differentiation, mediation of cytokine receptors
signaling and control of genes involved in the immune and
inflammatory responses [74–76], further supports the possible role
of SERPINB3 in immune response.
In conclusion, the present work shows a positive selection
signature throughout SERPINB3/B4 phylogeny, which may be a
major force driving the functional divergence of SERPINB3 and
B4 duplicates. Ultimately, adaptive evolution led to different
protease specificities providing SERPINB3 and B4 with the
ability to inhibit a broader repertoire of endogenous and
exogenous proteases. Furthermore, the retention of SERPINB3
and B4 duplicates in the H. sapiens, P. troglodytes and G. gorilla
clade could have a selective advantage in host-pathogen interac-
tions due to an adaptive response against infectious diseases in
Africa, during the evolution of great apes. Also, our results show
that SERPINB3 duplicate is being subject to strong positive
selection that could derive as well from ongoing host-pathogen
coevolution. The interaction of host protease inhibitors with
invasive proteases of pathogens can constitute a strong evolution-
ary pressure for the host to counteract by evolving new and
effective inhibitors. Above all, the search for a positive selection
signal among inhibitors and target proteases could contribute for a
better understanding of the complex interactions involving both
types of molecules and how its imbalance could lead to the onset of
different types of carcinomas and immune diseases, having
potential therapeutical implications.
Supporting Information
Figure S1 Primer annealing positions within SERPINB3
and SERPINB4 cDNA. Underlined: 59 - TGGAAATACCA-
TACAAAGGCA – 39 primer annealing position. Highlighted in
red: unique 59 – TGTAGGACTCCAGATAGCAC – 39 and 59-
TGTAGGACTTTAGATACTGA – 39 annealing positions. PCR
was programmed as follows: initial denaturation at 95uC for 10
minutes, followed by 35 cycles of denaturation at 94uC for 30
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seconds, annealing at 54uC for 30 seconds and extension at 72uC
for 30 seconds and a final extension at 60uC for 30 minutes.
(TIF)
Figure S2 Multipipemaker SERPINB3 and SERPINB4
alignment. Hsapiens: Homo sapiens; Ptroglodytes: Pan troglo-
dytes; Ggorilla: Gorilla gorilla; Pabelli: Pongo abelli; Nleucogenys:
Nomascus leucogenys; Mmulatta: Macaca mulatta; Panubis: Papio
Anubis; Cjacchus: Callithrix jacchus; Sboliviensis: Saimiri boli-
viensis
(PDF)
Figure S3 Branch-site analysis for SERPINB3/B4 genes,
foreground and background groups.
(TIFF)
Figure S4 Branch-site analysis for CTSS, foreground
and background groups.
(TIFF)
Figure S5 UCSC ENCODE annotation of transcript
factors obtained by CHIP-seq experiments for SER-
PINB3 and SERPINB4.
(TIF)
Figure S6 A) CTSG and CMA1 expression pattern showing an
ubiquitous expression profile for CTSG. B) Heat map and
hierarchical bi-clustering of the expression sequence tag (EST)
data of SERPINB3/B4 and their target proteases. The data for 45
normal tissues were extracted from NCBI UNIGENE and
normalized by total number of transcripts per library. Red and
green correspond to the high and low expression levels,
respectively. Black represents an average level of expression.
(TIF)
Table S1 Genomic locations for the DNA sequences
retrieved from the National Center for Biotechnology
Information database (NCBI) and University of Califor-
nia Santa Cruz (USCS) Genomic Bioinformatics data-
base for the nine primate species.
(DOCX)
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